From Casetext: Smarter Legal Research

Cesca Therapeutics Inc. v. Syngen Inc.

United States District Court, Ninth Circuit, California, E.D. California
Mar 25, 2015
2:14-cv-02085-GEB-KJN (E.D. Cal. Mar. 25, 2015)

Opinion


CESCA THERAPEUTICS INC., Plaintiff, v. SYNGEN INC., a California corporation; PHC MEDICAL, INC., a California corporation; PHILIP COELHO, an individual; TERRENCE WOLF, an individual; PRINCE EMMANUEL, an individual; and DOES 1 through 10, inclusive; Defendants. No. 2:14-cv-02085-GEB-KJN United States District Court, E.D. California. March 25, 2015

          ORDER

          GARLAND E. BURRELL, Jr., Senior District Judge.

         The joint stipulation filed March 23, 2015, (ECF No. 34), reveals this case is not ready to be scheduled. Therefore, the Status (Pretrial Scheduling) Conference scheduled for hearing on April 20, 2015, is continued to June 22, 2015, at 9:00 a.m. A joint status report shall be filed no later than fourteen (14) days prior to the Status Conference.

         Further, in light of the stipulation the pending motion to compel arbitration, (ECF No. 31), is deemed withdrawn; therefore, the April 13, 2015 hearing on that motion is vacated.

         IT IS SO ORDERED.


Summaries of

Cesca Therapeutics Inc. v. Syngen Inc.

United States District Court, Ninth Circuit, California, E.D. California
Mar 25, 2015
2:14-cv-02085-GEB-KJN (E.D. Cal. Mar. 25, 2015)
Case details for

Cesca Therapeutics Inc. v. Syngen Inc.

Case Details

Full title:CESCA THERAPEUTICS INC., Plaintiff, v. SYNGEN INC., a California…

Court:United States District Court, Ninth Circuit, California, E.D. California

Date published: Mar 25, 2015

Citations

2:14-cv-02085-GEB-KJN (E.D. Cal. Mar. 25, 2015)